Wilson Sonsini & Rosati has hired Mark Bellomy as a partner for the firm’s technology transaction practice in Boston.
Bellomy has worked in the Boston life-sciences industry for 20 years and has advised public and private companies, investors and institutions on tech transactions and IP.
Throughout his career, he has represented AstraZeneca, G1 Therapeutics and Pfizer in life science partnership deals.
Doug Clark, managing partner at Wilson Sonsini, said: “Heightened business activity among companies and investors in many life sciences sectors—due in part to efforts aimed at battling the pandemic—has increased demand among our clients for deal-making expertise, particularly R&D agreements, collaborations, and other sophisticated transactions.
“Mark’s 20-plus years of experience representing life sciences clients in all types of deals will be of great value to companies, investors, and institutions in the industry. We know he’ll make important and enduring contributions to the work of our clients, including those in the biopharmaceutical and medtech sectors.”
Prior to joining, Bellomy was a partner in IP transactions and life sciences groups at Ropes & Gray. He began his career as an associate there in 2000 and was promoted to partner in 2010. Prior to attending law school, Bellomy served as an officer in the US Army.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox.